Slope chart showing the annual number of FDA drug quality assurance inspections by region, by where the drug originated in. In 1012 there were slightly over 2k inspections, with 1,392 of them originating from the U.S. It stayed consistently above 1.6k till 2020, when it dropped below 500, only three of which were from China. In 2022 there was just over 600, with 467 of them in the U.S.